Chloroacetaldehyde
CAA
metabolite
alkylating agent
ifosfamide
IFO
renal damage
anti-tumor therapy
IFO
Depletion
sulfhydryl
SH
groups
cell culture
animal
clinical studies
effect
CAA
human
tubule cells
primary culture
hRPTEC
investigated
Toxicity
CAA
protein content
cell number
LDH
release
trypan blue exclusion assay
caspase-3
activity
Free thiols
method
Ellman
CAA
reduced
hRPTEC cell number
protein
induced
loss
free
intracellular
thiols
increase
necrosis
markers
CAA
acrolein
inhibited
cysteine proteases
caspase-3
caspase-8
cathepsin B. Caspase
activation
cisplatin
inhibited
CAA
cells
fluorescent dyes
targeting
lysosomes
CAA
induced
increase
lysosomal size
lysosomal leakage
effects of
CAA
cysteine protease
activities
thiols
cell lysate
Acidification
reaction
CAA
thiol donors
attenuate
effects
CAA
necrosis
markers
thiol
depletion
cysteine protease
inhibition
living cells
CAA
cellular protein
non-protein thiols
toxicity
hRPTEC
effect
reduced
acidification
urinary acidification
IFO nephropathy
patients
